Recent Blog Articles
Tick season is expanding: Protect yourself against Lyme disease
What? Another medical form to fill out?
How do trees and green spaces enhance our health?
A muscle-building obsession in boys: What to know and do
Harvard Health Ad Watch: New drug, old song, clever tagline
Concussion in children: What to know and do
What color is your tongue? What's healthy, what's not?
Your amazing parathyroid glands
When — and how — should you be screened for colon cancer?
Co-regulation: Helping children and teens navigate big emotions
Prostate Knowledge Archive
Articles
A patient’s story: Overcoming incontinence
How one man persisted for almost two years in an effort to remedy one of the most bothersome possible side effects of prostate cancer treatment, and what men facing therapeutic decisions can learn from his experience.
Androgen-independent prostate cancer
When cancer advances despite primary hormone therapy
We often hear the term prostate cancer and assume it is one disease. Practically speaking, it is. On a molecular level, however, scientists are revealing a far more complex picture. Cancer has an innate ability to adapt to its surroundings. As it progresses, cancer cells tend to change, morphing to a point where the differences between tumor cells can be dramatic. That’s why some researchers believe late-stage prostate cancer is more accurately described as a mix of cancer cell types.
Answering key clinical questions
An interview with renowned urology researcher E. David Crawford, M.D., about the state of clinical trials on prostate health
Can hormone therapy extend the lives of men with advanced prostate cancer? Might a drug traditionally prescribed to treat benign prostatic hyperplasia (BPH) help prevent prostate cancer? Does a short course of hormone therapy prior to a radical prostatectomy prevent or delay cancer’s return?
Promising technologies for the treatment of prostate cancer
Marc B. Garnick, M.D., provides an overview of possible treatments that need more study, including cryotherapy, HIFU, and focal therapies.
How to handle a relapse after treatment for prostate cancer
Marc B. Garnick, M.D., discusses what biochemical recurrence means and what your options are.
Possible complications of hormone therapy
Three Harvard-affiliated physicians discuss the impact that hormone therapy can have on bones and cardiovascular health.
Intermittent hormone therapy for prostate cancer
Marc B. Garnick, M.D., discusses this therapy, which aims to strike a balance between effective treatment and quality of life.
Hormone therapy for prostate cancer
Marc Garnick, M.D., Editor in Chief of the Annual Report on Prostate Diseases, discusses what you need to know about therapy: when it’s used, what your options are, and what doctors disagree about.
When to consider active surveillance
Which men are candidates for active surveillance? Some studies suggest that men with low risk cancer should consider active surveillance over traditional treatment, but the evidence is mixed.
Early-stage prostate cancer: Treat or wait?
When it comes to early-stage prostate cancer, there is no evidence that one treatment is better than another or that any treatment at all actually prolongs life. If you are diagnosed with early-stage prostate cancer, you’ll want to consider factors such as your values, your quality of life, and the potential side effects of various treatments before making a decision.
Recent Blog Articles
Tick season is expanding: Protect yourself against Lyme disease
What? Another medical form to fill out?
How do trees and green spaces enhance our health?
A muscle-building obsession in boys: What to know and do
Harvard Health Ad Watch: New drug, old song, clever tagline
Concussion in children: What to know and do
What color is your tongue? What's healthy, what's not?
Your amazing parathyroid glands
When — and how — should you be screened for colon cancer?
Co-regulation: Helping children and teens navigate big emotions
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up